Institute for Basic Science (IBS)
기초과학연구원

South Korea

IBS was established in 2011 aiming at advancing the frontiers of knowledge and fostering leading scientists of tomorrow by pursuing excellence in basic science research. Since then, IBS has been providing infrastructure for long-term, large-scale, and group research as well as supporting autonomous research activities of researchers, focusing on exploration of creative knowledge. In 2018, IBS had moved to its new building in Daejeon, South Korea. Watch the tour video of our headquarters and some of our research centers.

As a basic science research institute representing Korea, IBS is running 31 Centers in physics, chemistry, mathematics, life sciences, and interdisciplinary areas as of January 2021 and planning to increase the number to 50. IBS has announced 2021 call for applications for IBS Research Center Directors and Chief Investigators. Applications will be accepted until March 2, 2021. For more information, please visit www.ibs.re.kr/eng/sub04_02_04_01.do.

The institute’s main philosophy is to select a world renowned scientist as a Center’s director and create an environment where the director can concentrate on his/her own creative research. That is because IBS believes that creativity can be maximized when excellent researchers focus on conducting challenging research in an autonomous research environment.

IBS has been generating research outcomes that attract world-wide attention and was named one of Nature Index Rising Stars 2016. Despite a short history, the institute is standing shoulder to shoulder with international basic science research institutes. With the 2018 completion of its new headquarters designated as an urban science park, IBS will maximize merits of group and interdisciplinary research as well as bring IBS’ research capabilities together. It will more actively recruit young researchers at home and abroad with its expansion, heralding an even brighter future.

Since 2016, IBS has been operating Young Scientists Fellowship (YSF) under the slogan ‘Initiate your own research at IBS. In order to intensify its support to grow the next-generation leaders of scientific investigators, IBS has been launching a new research unit called Pioneer Research Centers (PRC), a subset of the existing IBS HQ Centers since early 2019. PRCs consist of up to five Chief Investigators (CIs) each. A CI leads their own research group to pioneer new fields and focus on challenging research in the basic sciences. CIs are required to have scientific excellence equivalent to that of a principle investigator at a globally renowned research institute or to have great potential to reach the aforementioned level in the near future. IBS will continue its efforts to become a research hub where young scientists can devote themselves to their science with full autonomy and independence.

1 September 2020 - 31 August 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Institute for Basic Science (IBS) published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count	Share
307	80.61

Outputs by subject (Share)

Subject	Count	Share
Physical Sciences	175	45.27
Earth & Environmental Sciences	12	2.23
Chemistry	140	37.99
Life Sciences	48	12.44

Highlight of the month

Implantable drug-delivery device could save lives in epilepsy

© KATERYNA KON/SCIENCE PHOTO LIBRARY/Getty Images

A wireless implantable device combined with wearable sensors could detect a potentially fatal medical emergency such as an epileptic seizure and automatically deliver a dose of medication.

A team led by researchers from the Institute for Basic Science in South Korea has developed a soft implantable drug-delivery device that can be inserted under the skin of the wrist. It interfaces wirelessly with a headband equipped with sensors that monitor electrical brain activity. A separate power transmitter, resembling a watch, is placed above the implanted device.

If the wearer experiences a medical crisis such as a seizure, the sensors detect it and send a signal to the power transmitter to trigger the implanted drug-delivery system.

A trial in mice showed that the device can deliver a life-saving dose of medication.

Supported content